StockVS

Streamex Corp. (STEX) Stock Analysis

Financial Services

Streamex Corp.

$1.41

+$0.13 (+10.16%)

Last Updated: May 26, 2026

Price History

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Company Overview

Streamex Corp. operates within the financial services sector, specifically focusing on capital markets through the provision of institutional-grade infrastructure for real world asset (RWA) tokenization. The company specializes in offering gold-denominated treasury solutions and advanced tokenization technology designed to enhance efficiency within the commodities markets. As of the latest reporting period, the entity employs a workforce of five individuals while maintaining a market capitalization of $236.48 million. This valuation presents a significant disparity relative to its reported annual revenue of $13,000, suggesting that the market capitalizes the company based on strategic potential, proprietary technology, or asset backing rather than current cash flow generation. The substantial market cap compared to the negligible revenue figure indicates that the company's position in the market is currently defined by speculative valuation metrics and future growth expectations rather than established operational profitability.

Financial Health

The company reported a total revenue of $13,000 over the trailing twelve months, yet it simultaneously recorded a net income of $-39,892,000, highlighting a severe disconnect between top-line activity and bottom-line profitability. The EBITDA stands at $-28,549,000, which further illustrates that the company is burning significant cash on operations before considering financing costs. The gap between the minimal revenue and the massive net loss reveals a cost structure where expenses vastly outweigh any income generated from core business activities. Despite the negative net income and EBITDA, the company reports a free cash flow of $119.09 million, which provides a layer of financial flexibility not typically seen in loss-making entities, potentially stemming from prior asset sales or large cash reserves. The balance sheet shows a cash position of $11.04 million against debt that is listed as N/A, meaning specific debt obligations are not disclosed in the available data. With a current ratio of 0.12, the company's short-term liquidity is constrained, as its current assets do not cover its current liabilities, indicating potential difficulty in meeting immediate obligations without external financing. The return on assets is -29.0%, while the return on equity is listed as N/A due to the negative equity situation implied by the financial structure. These negative return metrics reveal that management has not yet been effective in generating profit from the assets employed or the shareholders' capital.

Valuation Assessment

The trailing twelve-month P/E ratio is N/A, and the forward P/E is also N/A, indicating that the company has no positive earnings per share to support a traditional valuation multiple. The absence of a trailing and forward P/E implies that the market cannot value the stock based on earnings power, which is common for companies in a restructuring phase or those with massive losses. The price-to-book ratio is -6.28, a negative figure that technically indicates the market values the company at a discount relative to its book value, though this metric becomes less meaningful when equity is negative. The price-to-sales ratio is an extreme 18190.40, suggesting that the market is willing to pay more than eighteen thousand times the company's revenue, which points to a valuation driven entirely by future prospects rather than current financial performance. The EV/EBITDA stands at -1.32, reinforcing the lack of operational profitability that would normally support a standard enterprise value multiple. Regarding trading range, the stock has a 52-week high of $14.11 and a 52-week low of $0.40, meaning the current price sits somewhere within this volatile band, though the exact current price is not provided to calculate a precise percentage. The beta of 1.65 indicates that the stock price is significantly more volatile than the broader market, moving 65% more than the benchmark in either direction.

Growth & Income

The revenue growth year-over-year is N/A, and the earnings growth year-over-year is also N/A, meaning historical growth rates cannot be calculated to determine momentum. Since the earnings growth is N/A and revenue growth is N/A, it is impossible to state whether earnings are growing faster or slower than revenue, as both metrics lack a comparable prior period in the available data. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%. Because the payout ratio is 0.0%, the company retains all its earnings, or rather, all its cash, for reinvestment or to cover operating deficits rather than distributing income to shareholders. The overall growth and income profile is characterized by zero current income distribution and undefined historical growth rates due to the lack of comparative financial data in the provided facts.

Peer Comparison

Streamex Corp. (STEX) operates in the Capital Markets industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Streamex Corp. STEX $300.82M N/A
Morgan Stanley MS $317.08B 18.2
The Goldman Sachs Group, Inc. GS $293.39B 18.1
The Charles Schwab Corporation SCHW $155.48B 17.8

The Capital Markets industry average P/E ratio is 20.3x. Streamex Corp. trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Streamex Corp.

Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias. It also develops and operates the Streamex Exchange platform, a blockchain-based platform that facilitates the tokenization and exchange of real-world assets for the tokenized gold market. In addition, the company offers software support, maintenance, and upgrade services. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025. Streamex Corp. was incorporated in 2009 and is headquartered in Winter Park, Florida.

Visit website →

Key Statistics

Market Cap
$300.82M
P/E Ratio
N/A
52-Week High
$14.11
52-Week Low
$0.70
Avg Volume
1.72M

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
United States
Employees
6